| NCT Number | NCT07710664 |
| Lead Sponsor | Newish Biotech (Wuxi) Co., Ltd. |
| Conditions | Persistent HPV16 Infection |
| Enrollment | 10 participants |
| Start Date | 2026-07-20 |
| Primary Completion | 2026-12-30 (estimated) |
| Study Completion | 2027-06-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-17 |